Skip to content

Clinical trials

Lymphoma, B-Cell trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, B-Cell Clear all

772 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20011
20026
20036
20049
200514
200614
200717
200812
200913
201014
201113
201212
201318
201419
201520
201637
201744
201840
201954
202048
202158
202255
202361
202459
202556
202655

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed233
Recruiting147
Unknown status130
Terminated85
Active, not recruiting78
Not yet recruiting47
Withdrawn41
Suspended5
Enrolling by invitation4
No longer available1
Available1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)24
M.D. Anderson Cancer Center22
Fred Hutchinson Cancer Center11
Mayo Clinic9
Ruijin Hospital9
AstraZeneca8
Medical College of Wisconsin8
Memorial Sloan Kettering Cancer Center8
Seagen Inc.8
Second Affiliated Hospital, Zhejiang University, School of Medicine8

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, B-Cell772
Lymphoma, Non-Hodgkin183
Lymphoma, Large B-Cell, Diffuse156
Lymphoma142
Lymphoma, Follicular119
Recurrence111
Leukemia, Lymphocytic, Chronic, B-Cell100
Lymphoma, Mantle-Cell97
Burkitt Lymphoma77
Lymphoma, B-Cell, Marginal Zone66

Trials

Showing 76 to 100 of 772. Each trial links to its page on Pharma Observatory.

672 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.